Eiger BioPharmaceuticals, Inc.
AVEXITIDE FOR THE TREATMENT OF HYPERINSULINEMIC HYPOGLYCEMIA
Last updated:
Abstract:
Methods of treating hyperinsulinemic hypoglycemia (HH), including post-bariatric hypoglycemia (PBH) are provided. In some embodiments, the method comprises administering to a subject having HH a buffered liquid formulation composition.
Status:
Application
Type:
Utility
Filling date:
15 Oct 2019
Issue date:
4 Nov 2021